These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34804491)

  • 1. Association between metabolic syndrome components and the risk of developing nephrolithiasis: A systematic review and bayesian meta-analysis.
    Rahman IA; Nusaly IF; Syahrir S; Nusaly H; Mansyur MA
    F1000Res; 2021; 10():104. PubMed ID: 34804491
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
    Wong Y; Cook P; Roderick P; Somani BK
    J Endourol; 2016 Mar; 30(3):246-53. PubMed ID: 26576717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and stone disease.
    Soligo M; Morlacco A; Zattoni F; Valotto C; DE Giorgi G; Beltrami P
    Panminerva Med; 2022 Sep; 64(3):344-358. PubMed ID: 34609121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Urine Findings with Metabolic Syndrome Traits in a Population of Patients with Nephrolithiasis.
    Hood VL; Sternberg KM; de Waal D; Asplin JR; Mulligan C; Callas PW
    Kidney360; 2022 Feb; 3(2):317-324. PubMed ID: 35373120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Association of Metabolic Syndrome and Risk Factors of Nephrolithiasis.
    Karoli R; Fatima J; Karoli Y; Singh PS; Siddiqi Z; Shukla V; Khan FA
    J Assoc Physicians India; 2021 Jan; 69(1):32-35. PubMed ID: 34227773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between nephrolithiasis and diabetes mellitus, hypertension and gallstones: A meta-analysis of cohort studies.
    Lin BB; Huang RH; Lin BL; Hong YK; Lin ME; He XJ
    Nephrology (Carlton); 2020 Sep; 25(9):691-699. PubMed ID: 32525230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Behçet's disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis.
    Chen T; Shao X; Li H; Chen Y; Liu L; Zhong J; Chen J
    Clin Exp Med; 2023 Oct; 23(6):2855-2866. PubMed ID: 36939969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life.
    Lim JRZ; Scotland KB; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Bird VG; Andonian S; Bhojani N; Canvasser NE; Harper JD; Penniston KL; Chew BH
    J Endourol; 2020 Nov; 34(11):1203-1208. PubMed ID: 32689819
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.
    Rendina D; De Filippo G; D'Elia L; Strazzullo P
    J Nephrol; 2014 Aug; 27(4):371-6. PubMed ID: 24696310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: A systematic review and meta-analysis of observational evidence.
    Nano J; Muka T; Cepeda M; Voortman T; Dhana K; Brahimaj A; Dehghan A; Franco OH
    Diabetes Metab; 2016 Dec; 42(6):389-397. PubMed ID: 27396752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Syndrome and Nephrolithiasis; A Cross Sectional Population-based Study on the Baseline Data of the PERSIAN Kavar Cohort Study.
    Shojaei-Zarghani S; Safarpour AR; Askari H; Jahromi HK; Abbasi E; Fattahi MR
    Urology; 2023 Mar; 173():61-67. PubMed ID: 36435345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.
    Hagi K; Nosaka T; Dickinson D; Lindenmayer JP; Lee J; Friedman J; Boyer L; Han M; Abdul-Rashid NA; Correll CU
    JAMA Psychiatry; 2021 May; 78(5):510-518. PubMed ID: 33656533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
    Ding C; Yang Z; Wang S; Sun F; Zhan S
    Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis.
    Mardi P; Abdi F; Ehsani A; Seif E; Djalalinia S; Heshmati J; Shahrestanaki E; Gorabi AM; Qorbani M
    Front Endocrinol (Lausanne); 2022; 13():957136. PubMed ID: 36176470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?
    Khan SR
    Urol Res; 2012 Apr; 40(2):95-112. PubMed ID: 22213019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrolithiasis as a systemic disorder.
    Sakhaee K
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):304-9. PubMed ID: 18408483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: a multifaceted risk factor for kidney stones.
    Domingos F; Serra A
    Scand J Urol; 2014 Oct; 48(5):414-9. PubMed ID: 24708398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies.
    Shang W; Li Y; Ren Y; Yang Y; Li H; Dong J
    BMC Nephrol; 2017 Nov; 18(1):344. PubMed ID: 29187160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.